Automatic Immunoassay Analyzer Market By Product (Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System, Others) , By Application (Infectious Diseases, Endocrinology, Drug Monitoring, Chronic Diseases, Allergy Testing, Others) By End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The automatic immunoassay analyzer market was valued at $12.3 billion in 2023, and is projected to reach $51.4 billion by 2033, growing at a CAGR of 15.3% from 2024 to 2033.
Automatic immunoassay analyzer is an advanced medical device that performs immunoassays using antigen-antibody reactions to detect and quantify substances such as proteins, hormones, and drugs in biological samples. By automating the entire process, from sample preparation to result interpretation, these analyzers enhance efficiency, accuracy, and throughput in clinical and research settings. They are widely used in diagnostic laboratories, hospitals, and pharmaceutical industries to provide reliable and consistent results, thereby improving the speed and quality of patient care and research outcomes.
The growth of the global automatic immunoassay analyzer market is majorly driven by alarming rise in prevalence of chronic conditions such as cancer, cardiovascular diseases, and diabetes, which necessitate frequent and accurate diagnostic testing. According to a study published by the World Health Organization in September 2023, cardiovascular diseases are among the most prevalent most chronic diseases, accounting for 17.9 million deaths annually, followed by cancers with about 9.3 million deaths, and diabetes with 2.0 million deaths, including kidney disease deaths caused by diabetes. Furthermore, surge in geriatric population significantly contributes toward the market growth. This is attributed to the fact that as the population ages, there is an increased demand for diagnostic tests to monitor and manage age-related diseases, thereby boosting the market for automatic immunoassay analyzers. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. With increasing aged population, the incidence of chronic conditions is expected to rise significantly. Moreover, rise in awareness about the importance of early disease detection and preventive healthcare is leading to increased use of diagnostic tests, thus driving the demand for automatic immunoassay analyzers. Increase in trend toward personalized medicine, which requires precise and timely diagnostic information, is further accelerating the demand for reliable and high-throughput immunoassay systems. However, high initial investment and maintenance costs of advanced immunoanalyzers and need for regular maintenance, calibration, and technical support restrain the market growth. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, growing trend toward integrating immunoassay analyzers with digital health platforms and electronic health records to streamline data management and improve the overall efficiency of laboratory workflows is expected to offer lucrative opportunities for the market growth during the forecast period. Furthermore, manufacturers are focusing on developing multiplex immunoassays, which allow the simultaneous measurement of multiple biomarkers from a single sample. Such developments are anticipated to open new avenues for the market growth in the coming years.
The global automatic immunoassay analyzer market is segmented into product, application, end user, and region. On the basis of the product, the market is categorized into immunofluorescence, chemiluminescence, enzyme linked fluorescent system, and others. By application, it is classified into infectious diseases, endocrinology, drug monitoring, chronic diseases, allergy testing, and others. Depending on end user, it is divided into hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the chemiluminescence segment is expected to dominate the market from 2024 to 2033.
On the basis of application, the infectious diseases segment was the major shareholder in 2023.
Depending on end user, the pharmaceutical & biotechnology companies segment is poised for significant growth in the automatic immunoassay analyzer market in the coming years.
Region wise, automatic immunoassay analyzers are likely to gain high prominence in North America in the near future.
Competition Analysis
Competitive analysis and profiles of the major players in the global automatic immunoassay analyzer market include Abbott, Meril Life Sciences Pvt. Ltd., BioMerieux, Arlington Scientific, F. Hoffmann-La Roche Ltd, Carolina Liquid Chemistries, Becton Dickinson and Company,, Bio-Rad Laboratories, Inc, PerkinElmer Inc., and AESKU.GROUP GmbH. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
Key Market Segments
By Product
Immunofluorescence
Chemiluminescence
Enzyme Linked Fluorescent System
Others
By Application
Infectious Diseases
Endocrinology
Drug Monitoring
Chronic Diseases
Allergy Testing
Others
By End User
Hospitals
Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Abbott
Meril Life Sciences Pvt. Ltd.
BioMerieux
Arlington Scientific
F. Hoffmann-La Roche Ltd
Carolina Liquid Chemistries
Becton Dickinson and Company,
Bio-Rad Laboratories, Inc
PerkinElmer Inc.
AESKU.GROUP GmbH
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Immunofluorescence
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Chemiluminescence
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Enzyme Linked Fluorescent System
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Others
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- CHAPTER 5: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Infectious Diseases
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Endocrinology
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Drug Monitoring
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Chronic Diseases
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- 5.6. Allergy Testing
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country
- 5.7. Others
- 5.7.1. Key Market Trends, Growth Factors and Opportunities
- 5.7.2. Market Size and Forecast, By Region
- 5.7.3. Market Share Analysis, By Country
- CHAPTER 6: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Diagnostic Laboratories
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Pharmaceutical And Biotechnology Companies
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Others
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- CHAPTER 7: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Automatic Immunoassay Analyzer Market
- 7.2.6.1. Market Size and Forecast, By Product
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Automatic Immunoassay Analyzer Market
- 7.2.7.1. Market Size and Forecast, By Product
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Automatic Immunoassay Analyzer Market
- 7.2.8.1. Market Size and Forecast, By Product
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Automatic Immunoassay Analyzer Market
- 7.3.6.1. Market Size and Forecast, By Product
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Automatic Immunoassay Analyzer Market
- 7.3.7.1. Market Size and Forecast, By Product
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Automatic Immunoassay Analyzer Market
- 7.3.8.1. Market Size and Forecast, By Product
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Automatic Immunoassay Analyzer Market
- 7.3.9.1. Market Size and Forecast, By Product
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Automatic Immunoassay Analyzer Market
- 7.3.10.1. Market Size and Forecast, By Product
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Automatic Immunoassay Analyzer Market
- 7.3.11.1. Market Size and Forecast, By Product
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Automatic Immunoassay Analyzer Market
- 7.4.6.1. Market Size and Forecast, By Product
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Automatic Immunoassay Analyzer Market
- 7.4.7.1. Market Size and Forecast, By Product
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Automatic Immunoassay Analyzer Market
- 7.4.8.1. Market Size and Forecast, By Product
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. Australia Automatic Immunoassay Analyzer Market
- 7.4.9.1. Market Size and Forecast, By Product
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Automatic Immunoassay Analyzer Market
- 7.4.10.1. Market Size and Forecast, By Product
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Automatic Immunoassay Analyzer Market
- 7.4.11.1. Market Size and Forecast, By Product
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Automatic Immunoassay Analyzer Market
- 7.5.6.1. Market Size and Forecast, By Product
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Automatic Immunoassay Analyzer Market
- 7.5.7.1. Market Size and Forecast, By Product
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Automatic Immunoassay Analyzer Market
- 7.5.8.1. Market Size and Forecast, By Product
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Automatic Immunoassay Analyzer Market
- 7.5.9.1. Market Size and Forecast, By Product
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Abbott
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Meril Life Sciences Pvt. Ltd.
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. BioMerieux
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Arlington Scientific
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. F. Hoffmann-La Roche Ltd
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Carolina Liquid Chemistries
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Becton Dickinson And Company,
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Bio-Rad Laboratories, Inc
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. PerkinElmer Inc.
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. AESKU.GROUP GmbH
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR IMMUNOFLUORESCENCE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR CHEMILUMINESCENCE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR ENZYME LINKED FLUORESCENT SYSTEM, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 7. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR INFECTIOUS DISEASES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR ENDOCRINOLOGY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR DRUG MONITORING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR CHRONIC DISEASES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR ALLERGY TESTING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 14. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 17. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 18. AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 19. NORTH AMERICA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 20. NORTH AMERICA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 21. NORTH AMERICA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 22. NORTH AMERICA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 23. U.S. AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 24. U.S. AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 25. U.S. AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 26. CANADA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 27. CANADA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 28. CANADA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. MEXICO AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 30. MEXICO AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 31. MEXICO AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. EUROPE AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 33. EUROPE AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 34. EUROPE AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 35. EUROPE AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 36. GERMANY AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 37. GERMANY AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 38. GERMANY AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 39. FRANCE AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 40. FRANCE AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 41. FRANCE AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 42. UK AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 43. UK AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 44. UK AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 45. ITALY AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 46. ITALY AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 47. ITALY AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 48. SPAIN AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 49. SPAIN AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 50. SPAIN AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 51. REST OF EUROPE AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 52. REST OF EUROPE AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 53. REST OF EUROPE AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 55. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 56. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 57. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. JAPAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 59. JAPAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 60. JAPAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 61. CHINA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 62. CHINA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 63. CHINA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 64. INDIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 65. INDIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 66. INDIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 67. AUSTRALIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 68. AUSTRALIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 69. AUSTRALIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 70. SOUTH KOREA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 71. SOUTH KOREA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 72. SOUTH KOREA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 73. REST OF ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 74. REST OF ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 75. REST OF ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 76. LAMEA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 77. LAMEA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 78. LAMEA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 79. LAMEA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 80. BRAZIL AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 81. BRAZIL AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 82. BRAZIL AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 83. SAUDI ARABIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 84. SAUDI ARABIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 85. SAUDI ARABIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 86. SOUTH AFRICA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 87. SOUTH AFRICA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 88. SOUTH AFRICA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 89. REST OF LAMEA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 90. REST OF LAMEA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION , 2024 - 2033 ($BILLION)
- TABLE 91. REST OF LAMEA AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 92. ABBOTT: KEY EXECUTIVES
- TABLE 93. ABBOTT: COMPANY SNAPSHOT
- TABLE 94. ABBOTT: OPERATING SEGMENTS
- TABLE 95. ABBOTT: PRODUCT PORTFOLIO
- TABLE 96. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 97. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
- TABLE 98. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
- TABLE 99. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
- TABLE 100. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
- TABLE 101. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 102. BIOMERIEUX: KEY EXECUTIVES
- TABLE 103. BIOMERIEUX: COMPANY SNAPSHOT
- TABLE 104. BIOMERIEUX: OPERATING SEGMENTS
- TABLE 105. BIOMERIEUX: PRODUCT PORTFOLIO
- TABLE 106. BIOMERIEUX: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 107. ARLINGTON SCIENTIFIC: KEY EXECUTIVES
- TABLE 108. ARLINGTON SCIENTIFIC: COMPANY SNAPSHOT
- TABLE 109. ARLINGTON SCIENTIFIC: OPERATING SEGMENTS
- TABLE 110. ARLINGTON SCIENTIFIC: PRODUCT PORTFOLIO
- TABLE 111. ARLINGTON SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 112. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
- TABLE 113. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
- TABLE 114. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
- TABLE 115. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
- TABLE 116. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 117. CAROLINA LIQUID CHEMISTRIES: KEY EXECUTIVES
- TABLE 118. CAROLINA LIQUID CHEMISTRIES: COMPANY SNAPSHOT
- TABLE 119. CAROLINA LIQUID CHEMISTRIES: OPERATING SEGMENTS
- TABLE 120. CAROLINA LIQUID CHEMISTRIES: PRODUCT PORTFOLIO
- TABLE 121. CAROLINA LIQUID CHEMISTRIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 122. BECTON DICKINSON AND COMPANY, : KEY EXECUTIVES
- TABLE 123. BECTON DICKINSON AND COMPANY, : COMPANY SNAPSHOT
- TABLE 124. BECTON DICKINSON AND COMPANY, : OPERATING SEGMENTS
- TABLE 125. BECTON DICKINSON AND COMPANY, : PRODUCT PORTFOLIO
- TABLE 126. BECTON DICKINSON AND COMPANY, : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 127. BIO-RAD LABORATORIES, INC: KEY EXECUTIVES
- TABLE 128. BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT
- TABLE 129. BIO-RAD LABORATORIES, INC: OPERATING SEGMENTS
- TABLE 130. BIO-RAD LABORATORIES, INC: PRODUCT PORTFOLIO
- TABLE 131. BIO-RAD LABORATORIES, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 132. PERKINELMER INC.: KEY EXECUTIVES
- TABLE 133. PERKINELMER INC.: COMPANY SNAPSHOT
- TABLE 134. PERKINELMER INC.: OPERATING SEGMENTS
- TABLE 135. PERKINELMER INC.: PRODUCT PORTFOLIO
- TABLE 136. PERKINELMER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 137. AESKU.GROUP GMBH : KEY EXECUTIVES
- TABLE 138. AESKU.GROUP GMBH : COMPANY SNAPSHOT
- TABLE 139. AESKU.GROUP GMBH : OPERATING SEGMENTS
- TABLE 140. AESKU.GROUP GMBH : PRODUCT PORTFOLIO
- TABLE 141. AESKU.GROUP GMBH : KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF AUTOMATIC IMMUNOASSAY ANALYZER MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN AUTOMATIC IMMUNOASSAY ANALYZER MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALAUTOMATIC IMMUNOASSAY ANALYZER MARKET
- FIGURE 10. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET SEGMENTATION, BY PRODUCT
- FIGURE 11. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR CHEMILUMINESCENCE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR ENZYME LINKED FLUORESCENT SYSTEM, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET SEGMENTATION, BY APPLICATION
- FIGURE 16. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR ENDOCRINOLOGY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR DRUG MONITORING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR ALLERGY TESTING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET SEGMENTATION, BY END USER
- FIGURE 23. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 24. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 25. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 26. AUTOMATIC IMMUNOASSAY ANALYZER MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 27. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 28. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 29. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 30. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 31. COMPETITIVE DASHBOARD
- FIGURE 32. COMPETITIVE HEATMAP: AUTOMATIC IMMUNOASSAY ANALYZER MARKET
- FIGURE 33. TOP PLAYER POSITIONING, 2023
- FIGURE 34. ABBOTT: NET SALES, 2021-2023 ($BILLION)
- FIGURE 35. ABBOTT: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. ABBOTT: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 38. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. BIOMERIEUX: NET SALES, 2021-2023 ($BILLION)
- FIGURE 41. BIOMERIEUX: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. BIOMERIEUX: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. ARLINGTON SCIENTIFIC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 44. ARLINGTON SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. ARLINGTON SCIENTIFIC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 47. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. CAROLINA LIQUID CHEMISTRIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 50. CAROLINA LIQUID CHEMISTRIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. CAROLINA LIQUID CHEMISTRIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. BECTON DICKINSON AND COMPANY, : NET SALES, 2021-2023 ($BILLION)
- FIGURE 53. BECTON DICKINSON AND COMPANY, : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. BECTON DICKINSON AND COMPANY, : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. BIO-RAD LABORATORIES, INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 56. BIO-RAD LABORATORIES, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. BIO-RAD LABORATORIES, INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 58. PERKINELMER INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 59. PERKINELMER INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 60. PERKINELMER INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 61. AESKU.GROUP GMBH : NET SALES, 2021-2023 ($BILLION)
- FIGURE 62. AESKU.GROUP GMBH : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 63. AESKU.GROUP GMBH : REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook